Insmed Incorporated Message Board

Why not a separate report on this since it is so important? Maybe later?

Any case gives a chance for some to buy early this AM if we don't get too big a spike up.

Concluded the nine-month dosing phase of a dog inhalation toxicity study of ARIKACE and submitted an unaudited interim report to the US Food and Drug Administration (FDA) stating that the macrophage response was similar to that seen in our previous three-month dosing study in dogs and that there was no evidence of neoplasia, squamous metaplasia or proliferative changes

Sentiment: Strong Buy

This is EXTREMELY good news.